A Multicenter Clinical Study Of The Sonablate? 450 (Sonablate) For The Treatment Of Locally Recurrent Prostate Cancer With Hifu
Posted Date: May 15, 2019
- Investigator: James Donovan
- Type of Study: Drug
The purpose of this research study is to evaluate the safety and effectiveness of the Sonablate? 450 in men with locally recurrent prostate cancer. The Sonablate? 450 is considered experimental (not approved by the Food and Drug Administration) in the United States.
Criteria:
To Qualify You Must Have Been Diagnosed With Recurrent Prostate Cancer Following External Beam Radia
Keywords:
Fsi-003 , Recurrent, Star, Cancer, Prostate
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu